Coffee: The Magical Bean for Liver Diseases

Overview

Journal World J Hepatol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2017 Jun 10

PMID 28596816

Citations 12

Authors

Ryan D Heath

Mihir Brahmbhatt

Asli C Tahan

Jamal A Ibdah

Veysel Tahan

Affiliations

Soon will be listed here.

Abstract

Coffee has long been recognized as having hepatoprotective properties, however, the extent of any beneficial effect is still being elucidated. Coffee appears to reduce risk of hepatocellular carcinoma, reduce advancement of fibrotic disease in a variety of chronic liver diseases, and perhaps reduce ability of hepatitis C virus to replicate. This review aims to catalog the evidence for coffee as universally beneficial across a spectrum of chronic liver diseases, as well as spotlight opportunities for future investigation into coffee and liver disease.

Citing Articles

Caffeine supplement, inflammation, and hepatic function in cirrhotic patients: A randomized, placebo- controlled, clinical trial.

Abbas-Hashemi S, Yari Z, Hatami B, Anushiravani A, Kolahdoozan S, Zamanian A Heliyon. 2025; 11(1):e41138.

PMID: 39758360 PMC: 11699412. DOI: 10.1016/j.heliyon.2024.e41138.

Deleterious Effects of Caffeine Consumption on Reproductive Functions of Female Wistar Rats.

Ogunwole E, Emojevwe V, Shittu H, Olagoke I, Ayodele F JBRA Assist Reprod. 2024; 28(4):658-669.

PMID: 39405421 PMC: 11622411. DOI: 10.5935/1518-0557.20240055.

Reassessing the Impact of Coffee Consumption on Liver Disease: Insights from a Large-Scale Cohort Study with IPTW Adjustment.

Yang K, Chang Y, Jeong S, Jang J, Ryu T Nutrients. 2024; 16(13).

PMID: 38999772 PMC: 11243528. DOI: 10.3390/nu16132020.

Nanoemulsions of L. (Decaffeinated) and L. Extracts as a Novel Approach for the Treatment of Carbon Tetrachloride-Mediated Liver Fibrosis.

Alamri E, Bayomy H, Mohamady Hussein M, Ozaybi N, Almasoudi S, Zidan N Antioxidants (Basel). 2024; 13(3).

PMID: 38539888 PMC: 10968094. DOI: 10.3390/antiox13030355.

Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up.

Tappata M, Farah M, Anugwom C, Bisrat E, Seid A, Debes J Am J Trop Med Hyg. 2023; 109(5):1161-1165.

PMID: 37696510 PMC: 10622489. DOI: 10.4269/ajtmh.23-0236.

References

La Vecchia C . Epidemiological evidence on coffee and digestive tract cancers: a review. Dig Dis. 1990; 8(5):281-6. DOI: 10.1159/000171259. View

Loftfield E, Freedman N, Dodd K, Vogtmann E, Xiao Q, Sinha R . Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors. J Nutr. 2016; 146(9):1762-8. PMC: 4997286. DOI: 10.3945/jn.116.233940. View

Ruhl C, Everhart J . Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005; 129(6):1928-36. DOI: 10.1053/j.gastro.2005.08.056. View

Tverdal A, Skurtveit S . Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003; 13(6):419-23. DOI: 10.1016/s1047-2797(02)00462-3. View

Inoue M, Kurahashi N, Iwasaki M, Tanaka Y, Mizokami M, Noda M . Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control. 2008; 20(5):741-50. DOI: 10.1007/s10552-008-9287-6. View

Lee K, Choi J, Jeong H . Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol. 2007; 45(11):2118-25. DOI: 10.1016/j.fct.2007.05.010. View

Muriel P, Arauz J . Coffee and liver diseases. Fitoterapia. 2009; 81(5):297-305. DOI: 10.1016/j.fitote.2009.10.003. View

Larsson S, Wolk A . Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007; 132(5):1740-5. DOI: 10.1053/j.gastro.2007.03.044. View

Tavani A, Bertuzzi M, Talamini R, Gallus S, Parpinel M, Franceschi S . Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol. 2003; 39(7):695-700. DOI: 10.1016/s1368-8375(03)00081-2. View

10.

Ong A, Wong V, Wong G, Chan H . The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography. Liver Int. 2011; 31(7):1047-53. DOI: 10.1111/j.1478-3231.2011.02555.x. View

11.

Molloy J, Calcagno C, Williams C, Jones F, Torres D, Harrison S . Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology. 2011; 55(2):429-36. DOI: 10.1002/hep.24731. View

12.

Gressner O, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner A . Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol. 2008; 49(5):758-67. DOI: 10.1016/j.jhep.2008.03.029. View

13.

Catalano D, Martines G, Tonzuso A, Pirri C, Trovato F, Trovato G . Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2010; 55(11):3200-6. DOI: 10.1007/s10620-010-1143-3. View

14.

Casiglia E, Spolaore P, Ginocchio G, Ambrosio G . Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993; 9(3):293-7. DOI: 10.1007/BF00146266. View

15.

Lai G, Weinstein S, Albanes D, Taylor P, McGlynn K, Virtamo J . The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer. 2013; 109(5):1344-51. PMC: 3778279. DOI: 10.1038/bjc.2013.405. View

16.

Tahan A, Tahan V . "Could a cup of coffee a day keep the liver doctor away?": One cup or two or more cups of coffee per day reduces the risk of death from cirrhosis. Turk J Gastroenterol. 2014; 25(4):470-1. DOI: 10.5152/tjg.2014.0030. View

17.

Khalaf N, White D, Kanwal F, Ramsey D, Mittal S, Tavakoli-Tabasi S . Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin Gastroenterol Hepatol. 2015; 13(8):1521-31.e3. DOI: 10.1016/j.cgh.2015.01.030. View

18.

Kim S, Shin M, Sugimoto K, Kim S, Imoto S, Kim K . Coffee Intake and Liver Enzyme Association in Korean Immigrants and Japanese: A Comprehensive Cross-Sectional Study. Dig Dis. 2016; 34(6):665-670. DOI: 10.1159/000448832. View

19.

Kennedy O, Roderick P, Buchanan R, Fallowfield J, Hayes P, Parkes J . Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016; 43(5):562-74. DOI: 10.1111/apt.13523. View

20.

Machado S, Parise E, de Carvalho L . Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. Braz J Infect Dis. 2013; 18(2):170-6. PMC: 9427488. DOI: 10.1016/j.bjid.2013.09.001. View